Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided GONB for Migraine Prophylaxis
NCT06432127Phase 4Not yet recruiting
- Sponsor
- Mahidol University
- Start
- May 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine comparing Placebo with Bupivacaine (2 arms). Primary endpoints: Change of Frequency headache day /month at Week 24 and Change of migraine attack day /month at Week 24. Planned start May 2024; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06432127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06432127.